Twist Bioscience Corporation operates as a leading synthetic biology firm, specializing in the production and sale of products developed from synthesized DNA. The company utilizes a unique DNA synthesis platform that facilitates the creation of artificial DNA by "writing" it directly onto silicon chips. Its extensive product catalog encompasses custom synthetic genes, specialized tools designed for sample preparation, comprehensive antibody libraries essential for pharmaceutical research and development, and advanced applications leveraging DNA for digital data storage. Twist Bioscience has…
The top 10 holdings for $ARKK: $TSLA $SPCX $TEM $CRCL $CRSP $COIN $TWST $HOOD $TXG $SHOP https://t.co/U9pGro0dvv
regarding specific trades best trades: $DELL $NTRA $P $CDNA $HTFL $CRWD $BP $ARKG $TWST $NTAP worst trades: $CRDO $AMD $BE $GOOGL $SPCX $RVMD what hurt me this month was holding onto some trades too long, I knew in the back of my mind that Tech was overcrowded, just didn't
On my $TWST position I literally received hate mail in DM's last November as it fell 15% after my entry Stock returned 700% in the next 11 months on my cost basis. Those same people hating now nowhere to be seen https://t.co/eCzAFScVrU
$ARKG Genomics nice continuation here! $SDGR $TWST $TXG $NTRA etc https://t.co/IxwGlJGUuZ
$ARKG Genomes acting well $TWST $SDGR $TXG $VCYT etc https://t.co/XxKtomLF9a
HERE ARE THE TOP 15 PERFORMERS OF 2026 1. $MRNA +639% 2. $SNDK +447% 3. $TWST +319% 4. $DELL +259% 5. $AXTI +215% 6. $MU +208% 7. $AEHR +200% 8. $PENG +192% 9. $MRVL +168% 10. $BE +155% 11. $AMD +147% 12. $INTC +143% 13. $LITE +124% 14. $OSCR +122% 15. $AAOI +117%…
13 analysts rate TWST Buy on consensus.
Consensus price target: $168.25 (+20.57% upside from $139.55)
| Insider | Date | Transaction | Shares | Value |
|---|---|---|---|---|
| Leproust Emily M. director, Chief Executive Officer | Oct 5, 2026 | Sale | 481 | $96.8K |
| Leproust Emily M. director, Chief Executive Officer | Oct 5, 2026 | Sale | 1,017 | $205.76K |
| Leproust Emily M. director, Chief Executive Officer | Oct 5, 2026 | Sale | 146 | $30.2K |
| Leproust Emily M. director, Chief Executive Officer | Oct 5, 2026 | Sale | 1,840 | $368.81K |
| Leproust Emily M. director, Chief Executive Officer | Oct 5, 2026 | Sale | 45 | $9.34K |
| Fiscal year | Revenue | Revenue YoY | Net income |
|---|---|---|---|
| 2025 | $376.57M | +20.32% | $-77.67M |
| 2024 | $312.97M | +27.69% | $-208.73M |
| 2023 | $245.11M | +20.41% | $-204.62M |
Stock data for TWST: Summary · AI Insight · Feed · News · Financials · Transcript · SEC Filings · Insider · Politics